Home » Stocks » HCYT

H-CYTE, Inc. (HCYT)

Stock Price: $0.0413 USD 0.0003 (0.73%)
Updated Jul 30, 2021 3:16 PM EDT - Market closed
Market Cap 5.97M
Revenue (ttm) 1.51M
Net Income (ttm) -5.63M
Shares Out 144.43M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $0.0413
Previous Close $0.0410
Change ($) 0.0003
Change (%) 0.73%
Day's Open 0.0444
Day's Range 0.0412 - 0.0480
Day's Volume 103,916
52-Week Range 0.0060 - 0.1500

News

There are no news available yet.

About HCYT

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute biologics for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Industry
Medical Devices
Stock Exchange
OTCMKTS
Ticker Symbol
HCYT
Full Company Profile

Financial Performance

In 2020, H-CYTE, Inc.'s revenue was $2.15 million, a decrease of -74.23% compared to the previous year's $8.35 million. Losses were -$6.46 million, -78.33% less than in 2019.

Financial Statements